Trends in kidney transplantation and living donor nephrectomy in Germany: a total population analysis from 2006 to 2021.

"Declarations Conflict of interestMrs. Eisenmenger is founder and director of RI Innovation GmbH. J. Huber is Medical Board member of the "Urologische Stiftung Gesundheit gGmbH," Chairman of the Working Group "Health Services Research, Quality and Economics" of the German Society of Urology e. V. and initiator of the "Entscheidungshilfe Prostatakrebs" (www.entscheidungshilfe-prostatakrebs.info). The latter is supported by Takeda Pharma, Janssen Cilag GmbH and Apogepha. Further he indicates support of scientific projects outside the submitted work by Intuitive Surgical and Coloplast. Luka Flegar is a consultant for BK Medical. All the other authors have no conflicts of interest to declare. Ethics approvalAll procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Ethics approval was not required. Consent to participate:Not applicable. Conflict of interest Mrs. Eisenmenger is founder and director of RI Innovation GmbH. J. Huber is Medical Board member of the "Urologische Stiftung Gesundheit gGmbH," Chairman of the Working Group "Health Services Research, Quality and Economics" of the German Society of Urology e. V. and initiator of the "Entscheidungshilfe Prostatakrebs" (www.entscheidungshilfe-prostatakrebs.info). The latter is supported by Takeda Pharma, Janssen Cilag GmbH and Apogepha. Further he indicates support of scientific projects outside the submitted work by Intuitive Surgical and Coloplast. Luka Flegar is a consultant for BK Medical. All the other authors have no conflicts of interest to declare."

"Funding Open Access funding enabled and organized by Projekt DEAL. The authors have received no external funding."